Exhaled nitric oxide for the diagnosis of asthma in children and adults: a systematic review
posterposted on 20.03.2020 by Susan Harnan, Munira Essat, Tim Gomersall, Paul Tappenden, Ruth Wong, R. Lawson, Ian Pavord, M. Everard
Poster sessions are particularly prominent at academic conferences. Posters are usually one frame of a powerpoint (or similar) presentation and are represented at full resolution to make them zoomable.
The fraction of exhaled nitric oxide (FeNO) is a marker of eosinophilic inflammation, which is associated with some forms of asthma. Asthma is currently diagnosed using a pathway of tests including spirometery, airway reversability (response to bronchodilator or course of inhaled corticosteroids (ICS)) and airway hyper-responsiveness (e.g. methocholine challenge). FeNO may be a useful diagnostic test in this pathway. This systematic review aimed to identify and synthsise evidence rating to the diagnostic accuracy of FeNO for asthma with a UK focus. We looked at the highest sum of sensitivity and specificity, as well as evidence about the potential for FeNO to be used as a rule-in test (high-specificity) or as a rule-out test (high-sensitivity).
EthicsThere is no personal data or any that requires ethical approval
PolicyThe data complies with the institution and funders' policies on access and sharing
Sharing and access restrictionsThe data can be shared openly
- The file formats are open or commonly used
Methodology, headings and units
- Headings and units are explained in the files